The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Villegas, E. N.
Right arrow Articles by Hunter, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Villegas, E. N.
Right arrow Articles by Hunter, C. A.
The Journal of Immunology, 2002, 169: 937-943.
Copyright © 2002 by The American Association of Immunologists

A Role for Inducible Costimulator Protein in the CD28- Independent Mechanism of Resistance to Toxoplasma gondii1

Eric N. Villegas2,*, Linda A. Lieberman*, Nicola Mason*, Sarah L. Blass*, Valerie P. Zediak*, Robert Peach{dagger}, Tom Horan{ddagger}, Steve Yoshinaga{ddagger} and Christopher A. Hunter3,*

* Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104; {dagger} Bristol-Myers Squibb Pharmacology Research Institute, Princeton, NJ 08543; and {ddagger} Amgen Inc., Thousand Oaks, CA 91320

Long-term resistance to Toxoplasma gondii is dependent on the development of parasite-specific T cells that produce IFN-{gamma}. CD28 is a costimulatory molecule important for optimal activation of T cells, but CD28-/- mice are resistant to T. gondii, demonstrating that CD28-independent mechanisms regulate T cell responses during toxoplasmosis. The identification of the B7-related protein 1/inducible costimulator protein (ICOS) pathway and its ability to regulate the production of IFN-{gamma} suggested that this pathway may be involved in the CD28-independent activation of T cells required for resistance to T. gondii. In support of this hypothesis, infection of wild-type or CD28-/- mice with T. gondii resulted in the increased expression of ICOS by activated CD4+ and CD8+ T cells. In addition, both costimulatory pathways contributed to the in vitro production of IFN-{gamma} by parasite-specific T cells and when both pathways were blocked, there was an additive effect that resulted in almost complete inhibition of IFN-{gamma} production. Although in vivo blockade of the ICOS costimulatory pathway did not result in the early mortality of wild-type mice infected with T. gondii, it did lead to increased susceptibility of CD28-/- mice to T. gondi associated with reduced serum levels of IFN-{gamma}, increased parasite burden, and increased mortality compared with the control group. Together, these results identify a critical role for ICOS in the protective Th1-type response required for resistance to T. gondii and suggest that ICOS and CD28 are parallel costimulatory pathways, either of which is sufficient to mediate resistance to this intracellular pathogen.




This article has been cited by other articles:


Home page
Int ImmunolHome page
J. M. Rojo, E. Pini, G. Ojeda, R. Bello, C. Dong, R. A. Flavell, U. Dianzani, and P. Portoles
CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'
Int. Immunol., April 1, 2008; 20(4): 577 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. H.-M. Tan, S. Y.-P. Goh, S.-C. Wong, and K.-P. Lam
T Helper Cell-specific Regulation of Inducible Costimulator Expression via Distinct Mechanisms Mediated by T-bet and GATA-3
J. Biol. Chem., January 4, 2008; 283(1): 128 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. P. Iliopoulou, J. Alroy, and B. T. Huber
CD28 Deficiency Exacerbates Joint Inflammation upon Borrelia burgdorferi Infection, Resulting in the Development of Chronic Lyme Arthritis
J. Immunol., December 15, 2007; 179(12): 8076 - 8082.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Dzierszinski, M. Pepper, J. S. Stumhofer, D. F. LaRosa, E. H. Wilson, L. A. Turka, S. K. Halonen, C. A. Hunter, and D. S. Roos
Presentation of Toxoplasma gondii Antigens via the Endogenous Major Histocompatibility Complex Class I Pathway in Nonprofessional and Professional Antigen-Presenting Cells
Infect. Immun., November 1, 2007; 75(11): 5200 - 5209.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. H. Wilson, C. Zaph, M. Mohrs, A. Welcher, J. Siu, D. Artis, and C. A. Hunter
B7RP-1-ICOS Interactions Are Required for Optimal Infection-Induced Expansion of CD4+ Th1 and Th2 Responses
J. Immunol., August 15, 2006; 177(4): 2365 - 2372.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Quiroga, V. Pasquinelli, G. J. Martinez, J. O. Jurado, L. C. Zorrilla, R. M. Musella, E. Abbate, P. A. Sieling, and V. E. Garcia
Inducible Costimulator: A Modulator of IFN-{gamma} Production in Human Tuberculosis
J. Immunol., May 15, 2006; 176(10): 5965 - 5974.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Vidric, A. T. Bladt, U. Dianzani, and T. H. Watts
Role for Inducible Costimulator in Control of Salmonella enterica Serovar Typhimurium Infection in Mice
Infect. Immun., February 1, 2006; 74(2): 1050 - 1061.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Vidric, W.-K. Suh, U. Dianzani, T. W. Mak, and T. H. Watts
Cooperation between 4-1BB and ICOS in the Immune Response to Influenza Virus Revealed by Studies of CD28/ICOS-Deficient Mice
J. Immunol., December 1, 2005; 175(11): 7288 - 7296.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
O. Atochina and D. Harn
LNFPIII/LeX-Stimulated Macrophages Activate Natural Killer Cells via CD40-CD40L Interaction
Clin. Vaccine Immunol., September 1, 2005; 12(9): 1041 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Loke, X. Zang, L. Hsuan, R. Waitz, R. M. Locksley, J. E. Allen, and J. P. Allison
Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection
PNAS, July 12, 2005; 102(28): 9872 - 9877.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Elias, L. R. Sardinha, K. R. B. Bastos, C. A. Zago, A. P. F. da Silva, J. M. Alvarez, and M. R. D. Lima
Role of CD28 in Polyclonal and Specific T and B Cell Responses Required for Protection against Blood Stage Malaria
J. Immunol., January 15, 2005; 174(2): 790 - 799.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Rummel, J. Batchelder, P. Flaherty, G. LaFleur, P. Nanavati, J. M. Burns, and W. P. Weidanz
CD28 Costimulation Is Required for the Expression of T-Cell-Dependent Cell-Mediated Immunity against Blood-Stage Plasmodium chabaudi Malaria Parasites
Infect. Immun., October 1, 2004; 72(10): 5768 - 5774.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. J. Mason, H.-C. Liou, and C. A. Hunter
T Cell-Intrinsic Expression of c-Rel Regulates Th1 Cell Responses Essential for Resistance to Toxoplasma gondii
J. Immunol., March 15, 2004; 172(6): 3704 - 3711.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Yagi, Y. Arimura, U. Dianzani, T. Uede, T. Okamoto, and T. Uchiyama
Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
J. Immunol., July 15, 2003; 171(2): 783 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. V. Parry, C. A. Rumbley, L. H. Vandenberghe, C. H. June, and J. L. Riley
CD28 and Inducible Costimulatory Protein Src Homology 2 Binding Domains Show Distinct Regulation of Phosphatidylinositol 3-Kinase, Bcl-xL, and IL-2 Expression in Primary Human CD4 T Lymphocytes
J. Immunol., July 1, 2003; 171(1): 166 - 174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.